Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 96.61M P/E - EPS this Y 26.00% Ern Qtrly Grth -
Income -85.12M Forward P/E -1.03 EPS next Y 27.50% 50D Avg Chg 53.00%
Sales - PEG -0.03 EPS past 5Y - 200D Avg Chg -44.00%
Dividend N/A Price/Book 0.61 EPS next 5Y 15.50% 52W High Chg -85.00%
Recommedations 1.80 Quick Ratio 6.62 Shares Outstanding 44.36M 52W Low Chg 96.00%
Insider Own 18.44% ROA -37.74% Shares Float 33.53M Beta 1.52
Inst Own 54.11% ROE -66.95% Shares Shorted/Prior 7.19M/6.99M Price 2.18
Gross Margin - Profit Margin - Avg. Volume 1,120,770 Target Price 21.17
Oper. Margin - Earnings Date Feb 22 Volume 647,848 Change -2.77%
About Immunic, Inc.

Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and other chronic inflammatory and autoimmune diseases, as well as to treat coronavirus disease. The company is also developing IMU-935, an inverse agonist of ROR?t; and IMU-856 for the restoration of the intestinal barrier function in patients suffering from diseases, such as inflammatory bowel disease, irritable bowel syndrome with diarrhea, immune checkpoint inhibitor induced colitis, and other intestinal barrier function diseases. Immunic, Inc. is headquartered in New York, New York.

Immunic, Inc. News
01/25/23 Immunic to Participate in Scientific and Investor Conferences in February
01/18/23 Quite a few insiders invested in Immunic, Inc. (NASDAQ:IMUX) last year which is positive news for shareholders
11/17/22 Immunic Touts Positive Vidofludimus Calcium Data In Multiple Sclerosis Candidate
11/17/22 Immunic Reports New Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis Supporting the Drug's Neuroprotective Potential
11/10/22 Immunic to Participate in Investor and Scientific Conferences in November and December
11/03/22 Immunic, Inc. Reports Third Quarter 2022 Financial Results and Provides Corporate Update
10/27/22 Immunic, Inc. to Announce Financial Results for the Third Quarter Ended September 30, 2022, and Provide Corporate Update
10/21/22 Analyst Downgrades Immunic After Lack of Details Drive Uncertainty
10/21/22 Immunic's Early Cut Data From Psoriasis Candidate Failed To Show Desired Activity Signal Over Placebo
10/20/22 Immunic Reports Pre-Planned Phase 1b Interim Analysis of IMU-935 in Psoriasis Patients Confounded by High Placebo Rate
10/10/22 Immunic, Inc. Announces $60.0 Million Oversubscribed Private Placement Equity Financing
10/04/22 Immunic to Participate in Scientific and Industry Conferences in October
09/20/22 Immunic Says Potential Inflammatory Disease Candidate Is Safe, Tolerable In Healthy Participants
09/20/22 Immunic Announces Positive Results from Single and Multiple Ascending Dose Parts of Its Phase 1 Clinical Trial of IMU-856 in Healthy Human Subjects
09/19/22 Multiple Sclerosis Is A Crowded Space, But This Stock Is A Potential 6X Multi-bagger
09/16/22 Immunic, Inc.'s (NASDAQ:IMUX) latest 13% decline adds to one-year losses, institutional investors may consider drastic measures
09/01/22 Immunic, Inc. to Participate in Investor Conferences in September
08/16/22 Immunic Receives Notice of Allowance for Composition-of-Matter Patent in the United States for IMU-856, a Small Molecule Modulator Targeting Restoration of Intestinal Barrier Function and Regeneration of Bowel Epithelium
08/04/22 Immunic, Inc. Reports Second Quarter 2022 Financial Results and Provides Corporate Update
08/02/22 Immunic, Inc. to Participate in the 2022 Wedbush PacGrow Virtual Healthcare Conference
IMUX Chatroom

User Image Rockstar201 Posted - 57 minutes from now

$IMUX just started my entry. 1500 shares. Let’s go 💪

User Image tickeron Posted - 33 minutes ago

$ERNA vs. $IMUX: which stock is the best to buy? #EternaTherapeutics https://srnk.us/go/4361323

User Image From_zero_2_zero Posted - 38 minutes ago

$IMUX been here since early Nov. Up to 7,500 shares at this point. Nice gains so far but unless this explodes with the Celiac thing coming up next week I’m here through to the vidofludimus update the back half of the year.

User Image VoxGeorge Posted - 41 minutes ago

$IMUX I'll take another 1k shares at 2.10, tyvm.

User Image olderman562 Posted - 47 minutes ago

$IMUX Picked up more to. Not 1.17 my first 2k shares but I'm still on the green... Feb 9... let's wait!!

User Image From_zero_2_zero Posted - 53 minutes ago

$IMUX already heavily invested I picked up another 100 at 2.07. Why not?

User Image DexterLABORATORY Posted - 55 minutes ago

$LCID $IMUX watching both today

User Image StockHunter88 Posted - 57 minutes ago

$IMUX 2.06 got scooped us quickly

User Image coujatrader Posted - 1 hour ago

$IMUX to be expected

User Image StockHunter88 Posted - 1 hour ago

$IMUX a little shake up this morning.

User Image canecoleman Posted - 1 hour ago

$IMUX Don't get impatient and forget all the catalysts that Immunic has in the month of February. One more tree shake to get rid of impatient retail before big moves occur.

User Image DexterLABORATORY Posted - 1 hour ago

$IMUX 🤔

User Image mrshort Posted - 1 hour ago

$IMUX Estimated S.I as on 1/27/22 18.29 Percent Please complete information please join me via stocktwits.com/mrshort, for stock alerts, news, chat rooms, squeeze ranking watchlist. We are consistency hitting profit with our trading strategy. GOLF Our members daily updated information of highly shorted stock, squeeze ranking, access to Chat rooms, IPO analysis, Daily watchlist, Market Watchlist.Catalyst.

User Image TimingTimingTiming Posted - 1 hour ago

$IMUX Green close today IMo

User Image coujatrader Posted - 2 hours ago

$IMUX never really moves until around 11 which is strange

User Image olderman562 Posted - 2 hours ago

$IMUX $I hate Mondays! Just stay calm...

User Image StockHunter88 Posted - 2 hours ago

$IMUX yeah yeah.

User Image canecoleman Posted - 2 hours ago

$IMUX A few % down at the bell, then a quick red to green, and a nice move toward $2.50 by EOD. Can you feel it?

User Image canecoleman Posted - 3 hours ago

$IMUX

User Image DexterLABORATORY Posted - 4 hours ago

$IMUX watching the market as a whole 🤔 Same old?

User Image StockHunter88 Posted - 4 hours ago

$IMUX they are stair stepping it so the boom to $5 is not so drastic..

User Image StockHunter88 Posted - 4 hours ago

$IMUX next leg up to 2.35 today. Mark it..

User Image DexterLABORATORY Posted - 4 hours ago

$TSLA $IMUX https://www.cnbc.com/2023/01/30/berenberg-upgrades-tesla-says-price-cuts-are-part-of-a-broader-strategy.html

User Image BluesClues01 Posted - 4 hours ago

$IMUX excited for this week and even more excited for Feb!

User Image coujatrader Posted - 5 hours ago

$IMUX another big week

User Image From_zero_2_zero Posted - 5 hours ago

$IMUX

User Image DexterLABORATORY Posted - 7 hours ago

$IMUX % OF FLOAT SHORTED 19.12% SHORT INTEREST 6.93M 01/13/23 PERFORMANCE 5 Day 25.14% 1 Month 60.00% 3 Month 26.55% YTD 60.00% 1 Year -81.00% Source Marketwatch

User Image ChartMill Posted - 10 hours ago

In the last month $IMUX has a been trading in the 1.25 - 2.30 range, which is quite wide. https://www.chartmill.com/stock/quote/IMUX/technical-analysis?key=4d948a45-1754-4820-b62f-53717e4188d1&utm_source=stocktwits&utm_medium=TA&utm_content=IMUX&utm_campaign=social_tracking

User Image canecoleman Posted - 14 hours ago

$IMUX Let's see 2.5M+ volume tomorrow! That will put us up over $2.50!

User Image canecoleman Posted - 16 hours ago

$IMUX will be a TOP gainer across all stocks in February. Book it.

Analyst Ratings
SVB Leerink Market Perform Oct 21, 22
Aegis Capital Buy Aug 8, 22
SVB Leerink Outperform Jun 3, 22
Piper Sandler Overweight May 18, 22
HC Wainwright & Co. Buy Sep 7, 21
Aegis Capital Buy Apr 15, 21
JMP Securities Market Outperform Mar 24, 21
SVB Leerink Outperform Oct 2, 20
Piper Sandler Overweight Aug 26, 20
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Neermann Joerg Director Director Nov 23 Buy 1.39 18,000 25,020 18,000 11/25/22
Vitt Daniel President and CEO President and CEO Nov 22 Buy 1.3499 8,000 10,799 376,877 11/23/22
Whaley Glenn Chief Financial Offi.. Chief Financial Officer Nov 07 Buy 1.495 5,000 7,475 20,510 11/08/22
Vitt Daniel President and CEO President and CEO Jun 03 Buy 3.0999 5,000 15,500 368,877 06/06/22
Whaley Glenn Chief Financial Offi.. Chief Financial Officer Jun 03 Buy 3.045 3,500 10,658 12,568 06/06/22
Muehler Andreas Chief Medical Office.. Chief Medical Officer May 12 Buy 5.10 3,500 17,850 297,986 05/16/22